Vincent Rajkumar/X
Dec 6, 2025, 06:32
Vincent Rajkumar: mSMART Risk Stratification of Myeloma
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester and Editor‑in‑Chief at Blood Cancer Journal, shared a post on X:
”Ahead of ASH25 here is our latest mSMART risk stratification of myeloma. Bookmark!
-Incorporates latest IMS IMWG high risk definition
-Defines double-hit myeloma
-Additional high risk categories.”
Find the full coverage of ASH25 in Hemostasis Today.
-
Mar 6, 2026, 12:02Wolfgang Miesbach: Targeted Anti-TFPI Therapy with Marstacimab Supports Joint Stability in Hemophilia A
-
Mar 6, 2026, 11:49Love-Preet Kalra: Honored to Receive The Robert Wartenberg Award 2026
-
Mar 6, 2026, 11:43Matthew D. Neal: Turning Platelet Desert Into a Lifesaving Oasis at WTA 2026
-
Mar 6, 2026, 11:35Intensive Clotting Factor Prophylaxis Does Not Prevent Severe PPH in VWD – JTH
-
Mar 6, 2026, 09:15Reza Bavarsad Shahripour: When the Ophthalmic Artery Tells the Story of the Carotid
-
Mar 6, 2026, 09:13Louise St. Germain Bannon: Advancing Thrombosis and Hemostasis Through a Global Community
-
Mar 6, 2026, 09:06Kathleen Freson: Protein C Deficiency as a Genetic Modifier of Severe Haemophilia A
-
Mar 5, 2026, 17:48Estelle Carminita։ What If the Origin of Platelet Dysfunction Starts in the Bone Marrow
-
Mar 5, 2026, 17:43Pierre Sabouret: The Best Antithrombotic Strategy in Patients with Atherosclerotic Stroke and AF